Apton Biosystems, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Apton Biosystems, Inc. - overview
Established
2012
Location
Pleasanton, CA, US
Primary Industry
Biotechnology
About
Founded in 2012 and based in California, US, Apton Biosystems, Inc. operates as a biotechnology company that develops a sequencing platform for genetic analysis. The firm was founded by Bryan Staker and Linda Liu. In August 2023, Pacific Biosciences of California, Inc.
acquired Apton Biosystems, Inc. from Khosla Ventures, Casdin Capital, and Kern Capital Management LLC for USD 110 million. Apton Biosystems, Inc. provides Super-Res sequencing and single-molecule detection systems for large-scale clinical applications such as early cancer detection and population sequencing.
Current Investors
Khosla Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics, Pharmaceutical Research & Development
Website
www.aptonbio.com
Verticals
Artificial Intelligence
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Apton Biosystems, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.